• Blog
  • Onco Immunotherapy Market

    Onco Immunotherapy Market

    Onco Immunotherapy Market
    Report code - SRHL130 Delivery - 2 Weeks

    Opportunities and Gaps in the Global Onco-Immunotherapy Market by Epidemiology, By Vari See more...

    Purchase Report

    This report, from Stratview Research, studies the global onco-immunotherapy market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

    The Burning Questions This Report Will Answer:

    1. Over 1.5 million people worldwide die from lung cancer per year; why does the disease still has an extremely poor prognosis with all the modern technology?
    2. What are the options available for accurate prediction of lung cancer?
    3. Which market is more lucrative pharma, diagnostics or surgery?
    4. Which technologies are available currently and how will the future technologies disrupt the market?

    The Global Onco-Immunotherapy Market: Highlights

    Oncologists believe that Immunotherapy could be that wonder therapy for cancer. Since 2016, this innovation shifted the way in which cancer is treated and has transformed care for many patients. In fact, ASCO estimates that immune checkpoint inhibitors could save 250,000 years of life for the U.S. patients with advanced lung cancer for whom a checkpoint inhibitor could be prescribed. Immune checkpoint inhibitors are medicines that release the brakes on the body’s immune system, unleashing it to fight cancer.

    Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer. It uses substances made by the body or in a laboratory to improve or restore immune system function. This report gives insight on the treatment of cancer patients with immunotherapy across different markets and brings out the gaps between existing way of therapeutics and the demand. It also explores the treatment of different types of cancer i.e. Lung, Breast, Colorectal, Melanoma, Prostate and others using immunotherapy and looks at the regulations, cost, and supply chain issues across the major markets.

    The report gives an aerial view of the market for the manufacturers as well as looks at the demands and gaps at the hospitals for suppliers and distributors. Covering all the major markets where immunotherapy has been approved for the treatment of cancer, this report gives a global insight in to the gaps and opportunities that exist in the market.

    Research Methodology

    Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, Product portfolio, New product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors 
    • Future outlook

    The Global Onco-Immunotherapy Market is segmented into the following categories: 

    By Variation in Therapy Algorithm

    • APAC
    • North America
    • Western Europe
    • Rest of The World

    By Epidemiology

    By Class of Drugs

    • Monoclonal Antibodies
    • Cancer Vaccines
    • Check Point Inhibitors &
    • Immunomodulators and
    • Interferons Alpha)

    By Diagnosis

    • Lung, Breast
    • Colorectal
    • Melanoma
    • Prostate
    • Head & Neck

    By End-User Location

    • Hospital
    • Clinics and
    • Home Based

    By Region

    • North America (Country Analysis: the USA, Canada)
    • Western Europe (Country Analysis: Germany, France, the UK)
    • Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: The Middle East, Africa, Rest of Europe and Others) 

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:

    Company Profiling

    • SWOT analysis of key players (up to 3 players)
    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview research offers custom research services across sectors. In the case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].


    •